about
Pharmacotherapy for Status EpilepticusThe adverse event profile of lacosamide: a systematic review and meta-analysis of randomized controlled trialsAntiepileptic drugs' tolerability and safety--a systematic review and meta-analysis of adverse effects in dogsLacosamide: a new approach to target voltage-gated sodium currents in epileptic disordersLong-term treatment with responsive brain stimulation in adults with refractory partial seizures.Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: final results of the RNS System Pivotal trial.The association between oxcarbazepine-induced maculopapular eruption and HLA-B alleles in a northern Han Chinese population.Phenobarbitone-induced haematological abnormalities in idiopathic epileptic dogs: prevalence, risk factors, clinical presentation and outcome.Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy.Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug DevelopmentAdult-onset temporal lobe epilepsy, cognitive decline, multi-antiepileptic drug hypersensitivity, and Hashimoto's encephalopathy: Two case studies.Absence of HLA-B*1502 and HLA-A*3101 alleles in 9 Korean patients with antiepileptic drug-induced skin rash: a preliminary study.Safety and tolerability of antiepileptic drug treatment in children with epilepsy.Anticonvulsant profiles of certain new 6-aryl-9-substituted-6,9-diazaspiro-[4.5]decane-8,10-diones and 1-aryl-4-substituted-1,4-diazaspiro[5.5]undecane-3,5-diones.Treating epilepsy across its different stages.Contemporary review of drug-induced pancreatitis: A different perspective.Adverse antiepileptic drug effects in new-onset seizures: a case-control study.Clinical utility of eslicarbazepine: current evidence.Carbamazepine hypersensitivity: progress toward predicting the unpredictableSafety of lamotrigine in paediatrics: a systematic review.International veterinary epilepsy task force consensus proposal: outcome of therapeutic interventions in canine and feline epilepsyThe plasma proteome, adductome and idiosyncratic toxicity in toxicoproteomics researchToxic epidermal necrolysis due to concomitant use of lamotrigine and valproic Acid.Epilepsy pharmacogenetics.Immune mediation of hypersensitivity adverse drug reactions: implications for therapy.In vitro testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review.Relationship Between Acute Benzodiazepine Poisoning and Acute Pancreatitis Risk: A Population-Based Cohort Study.New and investigational antiepileptic drugs.Genetic predisposition of life-threatening antiepileptic-induced skin reactions.Health-related quality of life in epilepsy patients receiving anti-epileptic drugs at National Referral Hospitals in Uganda: a cross-sectional study.Adverse effects of antiepileptic drugs: a brief overview of important issues.The genetics of antiepileptic drug-induced skin reactions.Drug safety evaluation of zonisamide for the treatment of epilepsy.The somatic comorbidity of epilepsy: a weighty but often unrecognized burden.Lacosamide in patients with pharmacoresistant epilepsy.A case of syndrome of inappropriate scretion of anti-diuretic hormone associated with sodium valproate.The adverse event profile of perampanel: meta-analysis of randomized controlled trials.The long-term safety of antiepileptic drugs.AMPA receptor inhibitors for the treatment of epilepsy: the role of perampanel.Pharmacokinetic of antiepileptic drugs in patients with hepatic or renal impairment.
P2860
Q26796689-DAB2FA2A-7785-46EB-AB08-6C267E2272BBQ27026195-FBBE015D-563F-4D0B-BC1B-C46619D9785CQ28071335-E3822559-743C-4754-84F5-4D601A1E189CQ28833549-74A0024F-346B-470B-AB5D-5AE82D25323DQ30407873-47D9DD1A-90B2-450D-BA37-58AA7BF679B9Q30409185-021AF5FA-8B0C-470F-9B28-5D087313EA67Q31122683-667A281E-A1E9-486B-A697-519AA7ACB962Q33415378-C842BD6C-3AB8-41E5-A694-9193FFBCAE5FQ33664128-3FA6CE12-D642-49FE-AC55-708DDD1F91EAQ33677979-6DC9BB88-423C-4C6C-94E4-001782FDDBF8Q34114877-0E7E96E8-34CF-4DD1-A76A-D153AD9DA8A7Q34116637-EC10786E-626D-4BB2-97C3-0AE4E37B0ACDQ34281872-9CF0C981-AFBD-4250-9CA9-B328B2E66878Q34358799-D7463C4F-7010-4CCC-B3F0-20595D8B13E5Q34409465-E3FE051A-5082-47B0-806A-A6D639BC5456Q34508837-901C7FE6-EB8C-42AA-BB57-EDD02FBA772CQ34555287-CA43A000-433D-4BA5-9437-3A064D88D892Q35087964-28F9A2AC-A520-4B62-B8E5-99D161F72B37Q35562371-67000AAD-B528-4429-8125-50F90C1E3646Q35662636-81A0E2C2-FD7F-46BC-B100-362289F7D8C8Q35757818-4FF13715-D9AB-479B-AC42-D64C301A4893Q36667345-218F558C-C1EB-42AB-9618-A26D822C2B4DQ37187073-EEE170E0-B427-49E6-BF91-9B3D0C71492DQ37486720-2A37492D-D346-48E7-89A1-9F72565EFBF3Q37510953-BABAE4E3-3D11-4C3F-9161-3ACA048CD180Q37605792-91D4C07A-7553-4F14-AA09-39D73254E3D9Q37624226-938EABBE-30BB-4EF3-9C4E-3EA1B87B8386Q37638688-F0FB1299-AF53-4505-81A1-2D3FA398B72EQ37650570-AADE574E-2613-418E-BF63-68681404E9C7Q37723581-5232C551-E89C-4947-8B5C-86A058FB044BQ37762256-5B6AE481-E39F-409B-AC5B-FB22593140FFQ37859622-15F67F18-768A-4427-A1B4-6A2AE8FBD1FDQ37887798-CA48FD24-FBAB-4584-9F7E-F986CC2ACC36Q38018125-10AAF3D1-138F-4CB8-9FB6-FEC8ADD50A5EQ38032922-A0F67100-6D85-42A9-8F11-6D70E624C396Q38091005-08E51550-44CE-4388-88D7-C7281FB628BFQ38100835-5381AE54-B096-4D2F-89D2-B42876915C2EQ38106856-B530F4AC-B36A-4E32-9524-2326C77EA4BEQ38112213-8DF0DEF3-6FE4-4577-AB63-B2D750DA2BDAQ38152329-4E1CEACC-F7D0-420A-8190-3D16B8E9347E
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Idiosyncratic adverse reactions to antiepileptic drugs.
@ast
Idiosyncratic adverse reactions to antiepileptic drugs.
@en
type
label
Idiosyncratic adverse reactions to antiepileptic drugs.
@ast
Idiosyncratic adverse reactions to antiepileptic drugs.
@en
prefLabel
Idiosyncratic adverse reactions to antiepileptic drugs.
@ast
Idiosyncratic adverse reactions to antiepileptic drugs.
@en
P2860
P1433
P1476
Idiosyncratic adverse reactions to antiepileptic drugs.
@en
P2093
Diego Franciotta
Gaetano Zaccara
P2860
P304
P356
10.1111/J.1528-1167.2007.01041.X
P577
2007-03-26T00:00:00Z